Mirae Asset Global ETFs Holdings’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$972K Sell
38,363
-1,653
-4% -$37.6K ﹤0.01% 1642
2026
Q1
$856K Sell
40,016
-206
-0.5% -$4.29K ﹤0.01% 1589
2025
Q4
$860K Buy
40,222
+818
+2% +$16.8K ﹤0.01% 1608
2025
Q3
$660K Sell
39,404
-7,379
-16% -$111K ﹤0.01% 1729
2025
Q2
$671K Sell
46,783
-4,470
-9% -$61.3K ﹤0.01% 1655
2025
Q1
$743K Buy
51,253
+2,251
+5% +$32K ﹤0.01% 1646
2024
Q4
$643K Buy
49,002
+2,801
+6% +$38.7K ﹤0.01% 1788
2024
Q3
$535K Buy
46,201
+3,899
+9% +$36.8K ﹤0.01% 1884
2024
Q2
$319K Buy
+42,302
New +$350K ﹤0.01% 2031

Other funds holding MD

Mirae Asset Global ETFs Holdings's MD Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Pediatrix Medical (MD) stake by 4.1% in Q2 2026, selling an estimated $37.6K and leaving 38,363 shares worth $972K. The position accounts for ﹤0.01% of the portfolio, ranked #1642.

Mirae Asset Global ETFs Holdings first reported a position in MD in Q2 2024 and has held it in 9 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 38,363 shares of Pediatrix Medical worth $972K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 1,653 Pediatrix Medical shares in Q2 2026, an estimated $37.6K.
  • Pediatrix Medical made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1642 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Pediatrix Medical in Q2 2024 and has held it in 9 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.